Physician profile
Nancy F Easterling
NPI 1568486124
$767.88
in general payments reported to CMS, 2019-2025
17 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $285 · 2022: $103 · 2023: $103 · 2024: $103 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $180.27 | 2021-2025 | Xifaxan |
| Lilly USA, LLC | $104.24 | 2022-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $83.99 | 2021-2024 | Rybelsus, Ozempic |
| Pfizer INC. | $55.14 | 2021 | |
| Abbott Laboratories | $49.14 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.62 | 2021-2024 | Jardiance |
| Abbvie INC. | $42.02 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $29.95 | 2024-2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $28.36 | 2021 | |
| Astellas Pharma US INC | $24.66 | 2021 | |
| Boston Scientific Corporation | $21.62 | 2025 | Watchman Access System |
| Xeris Pharmaceuticals, INC. | $18.63 | 2024 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $18.62 | 2021 | |
| Amgen INC. | $18.36 | 2025 | Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $16.01 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.62 | 2023 | Shingrix, Arexvy, Boostrix |
| Seqirus USA INC | $13.63 | 2024 | Flucelvax, Fluad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Easterling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.